Although naltrexone produced no significant behavioral effects, it significantly magnified the increase in the total PANSS score produced by the lower subperceptual dose of ketamine, but not the ...

the extended-release formulation Vivitrol was developed for monthly intramuscular injection. Vivitrol shows reduced peaks and minimal fluctuations in plasma levels of the drug, which may improve ...

Emergency department (ED) clinicians face multiple barriers in initiating naltrexone for alcohol use disorder (AUD), including a lack of screening protocols and limited treatment awareness.